Status:

COMPLETED

Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement

Lead Sponsor:

University of Minnesota

Conditions:

Heart Failure

Eligibility:

All Genders

18-80 years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this study is to determine if the delivery of cells just after implantation of left ventricular assist device will help to improve the pumping function of your heart and minimize heart ...

Detailed Description

Patients who meet the inclusion and exclusion criteria and agree to participate will be enrolled in the study. All the patients will have a baseline EKG, Laboratory tests, 2D ECHO and PET/CT imaging.D...

Eligibility Criteria

Inclusion

  • Severe LV dysfunction with EF \< 30% with cardiomyopathy ( Ischemic and non ischemic)
  • NYHA Class III and IV
  • No revascularization options available
  • LVAD placement as destination therapy or bridging to transplantation
  • Age between 18-80 years

Exclusion

  • History of recent malignancy( less than one year) .
  • Unstable hemodynamics at the time of the implant; defined by need for increasing vasopressor medication in the last 24 hours or blood pressure \< 70 systolic, or cardiac index \< 1.3 liters/min.
  • Coronary anatomy suitable for revascularization at the time of surgery
  • Pregnancy confirmed by positive urine test
  • Lactating mothers
  • Renal failure with serum creatinine \>3.0, or are receiving chronic dialysis support.
  • Inability to undergo PET/CT imaging.
  • A history of any significant recent bleeding disorder or coagulation profile of concern for acute bleeding, such as INR \>2.0 (not on anticoagulant), platelet count \<100,000, or hemoglobin \<8.0 gr/dl.
  • Patients with known infectious disease (Hepatitis, HIV) etc.
  • Patients with three times or more of the upper limits of normal enzymes.
  • \-

Key Trial Info

Start Date :

November 10 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 29 2016

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT00869024

Start Date

November 10 2011

End Date

March 29 2016

Last Update

March 13 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Of Minnesota

Minneapolis, Minnesota, United States, 55455

Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement | DecenTrialz